Cancer Drugs
Jemperli
Also known as: Dostarlimab, Anti-PD-1
Definition
Dostarlimab, a PD-1 inhibitor approved for dMMR/MSI-H endometrial cancer and certain solid tumors.
Detailed Explanation
Jemperli offers immunotherapy for mismatch-repair deficient tumors. It is used after prior therapy in endometrial cancer and shows high response rates in MSI-H disease.